Basic Information
| RNALocate ID: | RLID-D:11000552 |
| RNA Symbol: | hsa-miR-542-3p |
| Localization: | Microvesicle |
RNA Information
| RNA Name: | hsa-miR-542-3p |
| RNA ID: | miRBase:MIMAT0003389 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| Tissue/Cell Line: | Breast cell line|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells |
| Database: | EVmiRNA |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002490 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:11003400 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11003401 | Exosome | Brain tissue | 23382797 |
| RLID:11003402 | Exosome | Plasma | 23663360 |
| RLID-D:11001430 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-542-3p | Lymphoplasmacytic lymphoma | MNDR-E-MI-59042 |
| MNDR | hsa-miR-542-3p | Oral squamous cell carcinoma | MNDR-E-MI-59043 |
| MNDR | hsa-miR-542-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-59044 |
| MNDR | hsa-miR-542-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-59045 |
| MNDR | hsa-miR-542-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-59046 |
| MNDR | hsa-miR-542-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-59047 |
| MNDR | hsa-miR-542-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-59048 |
| MNDR | hsa-miR-542-3p | Her2-receptor positive breast cancer | MNDR-E-MI-59049 |
| MNDR | hsa-miR-542-3p | Breast cancer luminal | MNDR-E-MI-59050 |
| MNDR | hsa-miR-542-3p | Gastric cancer | MNDR-E-MI-59051 |
| MNDR | hsa-miR-542-3p | Alzheimer disease | MNDR-E-MI-59052 |
| MNDR | hsa-miR-542-3p | Urinary bladder cancer | MNDR-E-MI-59053 |
| MNDR | hsa-miR-542-3p | Dysautonomia familial | MNDR-E-MI-59054 |
| MNDR | hsa-miR-542-3p | Cardiovascular disease | MNDR-E-MI-59055 |
| MNDR | hsa-miR-542-3p | Uterine fibroid | MNDR-E-MI-59056 |
| MNDR | hsa-miR-542-3p | Lung cancer | MNDR-E-MI-59057 |
| MNDR | hsa-miR-542-3p | Parkinson disease | MNDR-E-MI-59058 |
| MNDR | hsa-miR-542-3p | Breast cancer | MNDR-E-MI-59059 |
| MNDR | hsa-miR-542-3p | Neuroendocrine neoplasia | MNDR-E-MI-59060 |
| MNDR | hsa-miR-542-3p | Pituitary neoplasms | MNDR-E-MI-59061 |
| MNDR | hsa-miR-542-3p | Pancreatic cancer | MNDR-E-MI-59062 |
| MNDR | hsa-miR-542-3p | Melanoma | MNDR-E-MI-59063 |
| MNDR | hsa-miR-542-3p | Rectum adenocarcinoma | MNDR-E-MI-59064 |
| MNDR | hsa-miR-542-3p | Nephroblastoma | MNDR-E-MI-59065 |
| MNDR | hsa-miR-542-3p | Colon cancer | MNDR-E-MI-59066 |
| MNDR | hsa-miR-542-3p | Colon adenocarcinoma | MNDR-E-MI-59067 |
| MNDR | hsa-miR-542-3p | Ovarian cancer | MNDR-E-MI-59068 |
| MNDR | hsa-miR-542-3p | Acromegaly | MNDR-E-MI-59069 |
| MNDR | hsa-miR-542-3p | Prostate adenocarcinoma | MNDR-E-MI-59070 |
| MNDR | hsa-miR-542-3p | Glioblastoma | MNDR-E-MI-59071 |
| MNDR | hsa-miR-542-3p | Astrocytoma | MNDR-E-MI-59072 |
| MNDR | hsa-miR-542-3p | Glioma | MNDR-E-MI-59073 |
| MNDR | hsa-miR-542-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-59074 |
| MNDR | hsa-miR-542-3p | Osteosarcoma | MNDR-E-MI-59075 |
| MNDR | hsa-miR-542-3p | Gastric adenocarcinoma | MNDR-E-MI-59076 |
| MNDR | hsa-miR-542-3p | Cervical squamous cell carcinoma | MNDR-E-MI-59077 |
| MNDR | hsa-miR-542-3p | Pituitary adenoma | MNDR-E-MI-59078 |
| MNDR | hsa-miR-542-3p | Lung squamous cell carcinoma | MNDR-E-MI-59079 |
| MNDR | hsa-miR-542-3p | Non-small cell lung cancer | MNDR-E-MI-59080 |
| MNDR | hsa-miR-542-3p | Lung adenocarcinoma | MNDR-E-MI-59081 |
| MNDR | hsa-miR-542-3p | Thyroid carcinoma | MNDR-E-MI-59082 |
| MNDR | hsa-miR-542-3p | Carcinoma renal cell | MNDR-E-MI-59083 |
| MNDR | hsa-miR-542-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-59084 |
| MNDR | hsa-miR-542-3p | Renal clear cell carcinoma | MNDR-E-MI-59085 |
| MNDR | hsa-miR-542-3p | Cholangiocarcinoma | MNDR-E-MI-59086 |
| MNDR | hsa-miR-542-3p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-59087 |
| MNDR | hsa-miR-542-3p | Hepatocellular carcinoma | MNDR-E-MI-59088 |
| MNDR | hsa-miR-542-3p | Acute myelocytic leukemia | MNDR-E-MI-59089 |
| MNDR | hsa-miR-542-3p | Colorectal cancer | MNDR-E-MI-59090 |
| MNDR | hsa-miR-542-3p | Nasopharynx carcinoma | MNDR-E-MI-59091 |
| MNDR | hsa-miR-542-3p | Multiple myeloma | MNDR-E-MI-59092 |
| MNDR | hsa-miR-542-3p | Nasopharyngeal cancer | MNDR-E-MI-59093 |
| MNDR | hsa-miR-542-3p | Cerebral hemorrhage traumatic | MNDR-E-MI-59094 |
| MNDR | hsa-miR-542-3p | Intracranial hemorrhage hypertensive | MNDR-E-MI-59095 |
| MNDR | hsa-miR-542-3p | Breast cancer her3+ negative | MNDR-E-MI-59096 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | AKT1 | Homo sapiens | RR00067017 |
TOP